Q3 2025 Earnings Call Transcript October 29, 2025 Align Technology, Inc. beats earnings expectations. Reported EPS is $2.61, ...

Q3 2025 Management View CEO Joseph Hogan reported, “third quarter revenues, Clear Aligner volumes and non-GAAP operating margins are all above our outlook,” emphasizing strong sequential growth in ...

Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the ...

OSAHS is one of the most prevalent sleep-related breathing disorders. Early signs often include habitual snoring caused by airway narrowing. As the condition progresses, patients may experience ...

Combined treatments for both aspects of obstructive sleep apnea (OSA)—a compromised airway anatomy and unstable breathing—have shown promise in a Monash and Harvard-led trial. Published in the ...

For the first time, researchers have shown that tackling obstructive sleep apnea’s two root causes at once, using both oxygen and a jaw-forwarding device, can dramatically cut breathing interruptions ...

Before the start of the season, the OHSAA made a major change to the qualification numbers for cross country. Teams that advance in the postseason now have their runners removed from individual ...

The Gracias Family Foundation has made a $20 million gift to the University of Chicago in support of faculty research and student advancement. This philanthropic investment will directly support the ...

Minister of Science and Technology Yin Hejun speaks at a news conference held by the CPC Central Committee on the guiding principles from the fourth plenary session of the 20th CPC Central Committee ...

Rani Therapeutics is initiated at a Buy rating, driven by major pipeline advancements and strong partnership momentum. RANI secured a $1.085 billion collaboration with Chugai Pharmaceutical, ...

This year marks the flagship report's 30th anniversary, showcasing J.P. Morgan's long-standing market expertise and leading research capabilities NEW YORK, Oct. 20, 2025 /PRNewswire/ -- J.P. Morgan ...